Who owns G50871955 - JAZZ PHARMACEUTICALS PLC - PUT based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

JAZZ PHARMACEUTICALS PLC - PUT Institutional Ownership

CUSIP G50871955 is the security identifier used in SEC filing datasets for G50871955 - JAZZ PHARMACEUTICALS PLC - PUT.

CUSIP: G50871955

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

What is CUSIP G50871955?
CUSIP G50871955 identifies G50871955 - JAZZ PHARMACEUTICALS PLC - PUT in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Open recent reporting periods for CUSIP G50871955:

As of 31 Dec 2025, 0 institutional investors reported holding shares of JAZZ PHARMACEUTICALS PLC - PUT.

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Price (Median)	Investors
2025 Q4				$1,530,000	$170.00	0
2025 Q3				$186,075	$131.00	0
2025 Q2				$84,000	$105.00	0
2025 Q1				$1,178,940	$124.11	0
2024 Q4				$172,205	$123.00	0
2024 Q3				$1,069,306	$111.37	0
2024 Q2				$960,456	$106.73	0
2024 Q1				$1,793,276	$120.42	0
2023 Q4				$5,707,100	$123.00	0
2023 Q3				$2,290,192	$129.44	0
2023 Q2				$470,131	$123.97	0
2023 Q1				$1,009,650	$146.32	0
2022 Q4				$8,252,362	$159.31	0
2022 Q3				$11,210,000	$133.29	0
2022 Q2	0	$0	-$4,670,000	$13,963,000	$156.02	0
2022 Q1	30,000	$4,670,000	+$4,670,000	$13,403,000	$155.67	1
2021 Q4				$18,205,000	$127.39	0
2021 Q3				$21,919,000	$155.69	0
2021 Q2				$29,985,000	$177.63	0
2021 Q1				$52,236,000	$164.68	0
2020 Q4				$41,295,000	$165.05	0
2020 Q3				$31,463,000	$142.61	0
2020 Q2				$838,000	$5565.00	0
2020 Q1				$707,000	$5028.06	0
2019 Q4				$5,224,000	$7537.32	0
2019 Q3				$6,099,000	$12807.02	0
2019 Q2				$1,354,000	$7162.22	0
2019 Q1				$4,960,000	$7216.99	0
2018 Q4				$818,000	$6256.42	0
2018 Q3				$4,455,000	$8487.53	0
2018 Q2				$17,936,000	$172.30	0
2018 Q1				$6,514,000	$151.00	0
2017 Q4				$7,508,000	$171.29	0
2017 Q3				$6,623,000	$148.13	0
2017 Q2				$3,521,000	$155.52	0
2017 Q1				$8,309,000	$145.13	0
2016 Q4				$2,991,000	$1128.38	0
2016 Q3				$19,512,000	$121.49	0
2016 Q2				$7,807,000	$141.32	0
2016 Q1				$14,084,000	$130.56	0
2015 Q4				$13,045,000	$140.58	0
2015 Q3				$11,822,000	$132.82	0
2015 Q2				$14,833,000	$176.08	0
2015 Q1				$19,364,000	$172.80	0
2014 Q4				$33,369,000	$163.73	0
2014 Q3				$38,647,000	$160.56	0
2014 Q2				$27,550,000	$147.01	0
2014 Q1				$29,942,000	$138.68	0